Skip to main content

Catlin unveils results of rights issue

Catlin Group has announced that under the terms of a 2 for 5 rights issue announced on 12 February 2009, valid acceptances have been received in respect of 98.68 per cent of the total number of new common shares offered to shareholders.

The Rights Issue was fully underwritten by JP Morgan Securities on behalf of J.P. Morgan Cazenove and UBS Limited.

In a statement Catlin added: "As disclosed on page 48 of the prospectus relating to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Diary of an Insurer: Rokstone’s Darren Guymer

Darren Guymer was hired as head of surety at Rokstone in June 2025. His working week sees him take a hands-on approach to building relationships with both carriers and brokers while also coaching his son’s under eight’s football team.

Q&A: Will Pritchett, Accenture UK and Ireland

Will Pritchett, insurance lead for Accenture UK and Ireland, talks to Insurance Post about how insurers can cope with changing demands as AI transforms the industry, and how the company’s role in supporting providers is evolving.

Axa aims to double schemes business

Sarah Mallaby, chief distribution officer and mid-market trading director at Axa Commercial, has revealed the provider is looking to double its schemes business as the firm looks to become a “£2bn business”.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here